Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Oregon for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Oregon only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Oregon (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

William Hinz (NPI 1538345145)

Field	Value
Entity Type	Individual
Organization	William Hinz
Address	1007 Harlow Rd
City	Springfield
State	OR
ZIP	97477
Taxonomy	Rheumatology Physician
NPI Enumerated	January 14, 2008

Payer Source	Total Paid
Medicare	$1.2M
Medicaid	$0

Key Findings

This provider’s Medicare-focused practice generates Total Medicare revenue of $1.2M while Total Medicaid revenue is none (no Medicaid billing on file), indicating an effectively single-payer (Medicare) billing profile with no recorded Medicaid activity. The absence of Medicaid claims suggests any contract or patient mix analysis should treat this entity as operating almost exclusively in the Medicare channel.

Revenue concentration is high: the precomputed top 3 Medicare codes by revenue account for 62.3% of this provider's total Medicare revenue, driven by J0129 (25.3%), J0897 (19.0%), and J1745 (18.0%). Those three biologic/injectable drug codes dominate the revenue picture, so drug administration and infusion services are the primary commercial drivers for this clinician.

The code mix signals an infusion-centric rheumatology practice: the top codes are J0129 (abatacept), J0897 (denosumab), J1745 (infliximab) and other IV biologic drugs such as J3262 (tocilizumab) and J1602 (golimumab). In addition to biologic administration, the presence of infusion/administration CPTs (e.g., 96365, 96413) and office E/M codes (99214, 99213) indicates the practice combines in-office infusions with routine outpatient follow-up visits rather than being a purely procedural or clinic-less drug dispenser.

Competitive standing is mixed by code: the provider ranks at higher national percentiles for several key biologic injections (J0897 ranks #801 of 10057, 92th percentile; J1745 ranks #151 of 1352, 89th percentile), indicating above-average national volume for those drugs, while J0129 sits near the middle of peers (ranks #575 of 1221, 53th percentile). Overall, the provider is not a dominant national outlier across all codes but does show relatively strong national positions for specific biologic agents.

There is a pronounced operational signal in administration intensity: 96415 (the add-on infusion hour code) is labeled notably above typical national volume and ranks #115 of 4959 providers (98th percentile), implying this clinician commonly delivers extended infusion sessions beyond the initial hour. That pattern aligns with high use of multi-hour IV biologics and suggests an infusion suite or protocol that regularly requires additional infusion time billing.

Some code-level volumes highlight different economics within the same practice: J3262 shows 36.6K claims at $4 avg paid/claim for $146.3K revenue (12.6% of Medicare revenue), a very large claim count but low per-claim payment, whereas J0129 has fewer claims (8.6K) and much higher revenue ($293.3K, 25.3%). This contrast suggests the practice bills a mix of high-frequency, low-pay injectable services alongside less frequent, higher-paid biologic administrations.

E/M and ancillary services are present but secondary to infusion revenue: 99214 accounts for 536 claims and $47.7K (4.1% of Medicare revenue) and typical lab and injection CPTs (e.g., 36415, 80053, 85025) each contribute only small single-digit percentages of Medicare revenue. Those figures indicate that while the provider manages outpatient follow-up and routine testing, the business model is primarily built around drug administration rather than office visits or diagnostic testing as primary revenue sources.

The provider has a long tenure on file, with NPI enumerated 2008-01-14 (~18 years ago), which supports the interpretation of an established practice with an operational history long enough to develop infusion workflows and payer relationships. Given the combination of long enrollment, concentrated biologic revenue (62.3% from the top three codes), and a Medicare-only billing footprint, analysts should treat this entity as an established, Medicare-focused rheumatology infusion provider with selective national-level strength on certain injectable therapies.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

32 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	8,630	$30	$293.3K
J0897	Injection, denosumab, 1 mg	12,240	$20	$220.3K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	8,010	$30	$208.3K
J3262	Injection, tocilizumab, 1 mg	36,570	$1	$146.3K
J1602	Injection, golimumab, 1 mg, for intravenous use	13,050	$10	$130.5K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	540	$90	$47.7K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	250	$100	$25.3K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	290	$60	$17.7K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	330	$50	$15.7K
20610	In this procedure, the provider inserts a needle through the skin of a patient and into a major joint or bursa and then uses the syringe attachment to the needle to remove fluid or he may inject a…	210	$50	$11.1K

Showing 1–10 of 32

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 32 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Oregon Distribution

William Hinz — 3 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Oregon

Full comparison — all codes billed, vs. state median

32 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	7	20	6,300	$30	$260.7K
J3262	5	10	31,180	$1	$176.4K
J1602	13	20	13,600	$10	$156.4K
J1745	4	20	3,750	$30	$115.2K
J0897	4	70	2,400	$20	$78.3K
96413	17	90	150	$100	$18.2K
99214	220	6,070	80	$70	$10.3K
Q0138	13	20	13,770	$1	$6.2K
96365	7	110	70	$50	$5.8K
99213	404	5,480	60	$50	$5.7K

Showing 1–10 of 32

Related Providers

Other providers that share a Tax Identification Number (TIN) with William Hinz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Oregon Healthcare Resources, LLC	OR	Multi-Specialty Clinic/Center	$0	$8.8M
Diman Lamichhane	TX	Rheumatology Physician	$2.1M	$0
Blake Sampson	UT	Dermatology Physician	$592.7K	$0
Dane Dougherty	OR	Rheumatology Physician	$505.9K	$0
Steven Wilhelm	WA	Diagnostic Radiology Physician	$439.1K	$0
Todd Knapp	OR	MOHS-Micrographic Surgery Physician	$369.3K	$0
Norbert Yee	WA	Diagnostic Radiology Physician	$320.9K	$0
Gregory Kujawski	WA	Diagnostic Radiology Physician	$284.9K	$0
Ryan Goff	TX	Diagnostic Radiology Physician	$270.9K	$0
Philip Smith	WA	Diagnostic Radiology Physician	$250.2K	$0

Nearby Providers

Other providers in the same ZIP code as William Hinz, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Mckenzie-willamette Regional Medical Center Associates LLC	OR	General Acute Care Hospital	$0	$44.6M
Peacehealth	OR	General Acute Care Hospital	$0	$30.7M
Lane County Oregon	OR	Federally Qualified Health Center (FQHC)	$0	$20.6M
Springfield Treatment Center	OR	Methadone Clinic	$0	$20.5M
Mental Health For Children, Inc	OR	Mental Health Counselor	$0	$12.7M
G Street Integrated Health	OR	Clinic/Center	$0	$9.3M
Radiology Associates PC	OR	Diagnostic Radiology Physician	$0	$7.8M
Oregon Endoscopy Center, LLC	OR	Ambulatory Surgical Clinic/Center	$919.2K	$5.6M
Pathology Consultants, PC	OR	Anatomic Pathology & Clinical Pathology Physician	$0	$5.5M
Peacehealth	OR	Hospitalist Physician	$0	$5.5M

William Hinz — Billing Profile & Reimbursement Data

Sign up for William Hinz — Billing Profile & Reimbursement Data policy alerts

William Hinz — Billing Profile & Reimbursement Data

Sign up for William Hinz — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References